688265 Shanghai Model Organisms Center, Inc.
- 25.68
- -0.32-1.23%
Shanghai Model Organisms Center, Inc. News
Nanmo Biology: third quarter report 2024
Third Quarter Report 2024
Nanmo Biotech Investor Relations Activity Record Form 2024-008
Legal Opinion of Shanghai AllBright Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Southern Model Biotechnology Co., Ltd.
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Nanmo Biology: Meeting materials of the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Southern Model Biotechnology Co., Ltd.
Meeting materials of the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Southern Model Biotechnology Co., Ltd.
Nanmo Biotech Investor Relations Activity Record Form 2024-007
Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Announcement on the Resignation of Non-Independent Directors and the By-election of Non-Independent Directors
Constitution of Shanghai Southern Model Biotechnology Co., Ltd. (Revised in September 2024)
Announcement on increasing the scope of business of the company and revising the “Articles of Association”
Announcement of Resolutions of the 16th Meeting of the Third Board of Directors
Nanmo Biotech: Announcement on the repurchase of the company\'s shares to reach 3% of the total share capital through centralized bidding transactions and the implementation results of the share repurchase
Nanmo Biotech: Announcement on holding the 2024 semi-annual results briefing
Announcement on the repurchase of the company\'s shares through centralized bidding transactions to reach 3% of the total share capital and the implementation results of the share repurchase
Announcement on holding the 2024 semi-annual results briefing
Nanmo Biotech: China International Finance Corporation\'s Verification Report on the Shareholders of Shanghai Nanfang Model Biotechnology Co., Ltd. requesting quotations and transfers of shares to specific institutional investors
Nanmo Biotech: Shareholder Inquiry and Transfer Results Report and Prompt Announcement of Changes in Shareholders\' Equity with 5% or More Shareholders\' Equity Changes of 1%
China International Finance Corporation Verification Report on Shareholders of Shanghai Southern Model Biotechnology Co., Ltd. requesting quotations and transfers of shares to specific institutional investors
Analysis
Price Target
No Data
No Data